By Connor Hart
Shares of Tenon Medical rose after the company received notice of two approvals from the European patent office.
The stock gained 40%, to $1.75, in after-hours trading Monday. Shares ended the regular session 3.8% lower, at $1.25, and have lost almost 90% of their value in the past year.
The Los Gatos, Calif., medical-device company said after the bell that two additional patents related to its Catamaran Sacroiliac Joint Fixation Device have been approved for grant of a European patent within the European Community.
"Receiving notification of approval for two additional patents by the European patent office reinforces Tenon's increasingly robust patent position worldwide as well as our commitment to continued innovation," Chief Technology Officer Richard Ginn said.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
March 10, 2025 17:28 ET (21:28 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。